ALNT · XBRL financial data

Allient financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ALNT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	366,694	403,516	502,988	578,634	529,968	554,478
Cost of goods and services sold	258,119	282,460	345,729	394,951	364,277	372,769
Gross profit	108,575	121,056	157,259	183,683	165,691	181,709
General and administrative	38,301	42,419	50,677	58,403	55,669	57,853
Total operating expenses	85,581	95,030	125,603	141,369	135,653	137,724
Operating income (loss)	22,994	26,026	31,656	42,314	30,038	43,985
Interest expense	3,716	3,236	7,692	12,383	13,296	13,175
Other income (expense)	(502)	323	(283)	(231)	116	(2,076)
Income tax expense (benefit)	5,133	(981)	6,292	5,603	3,692	6,700
Earnings per share, basic‡ USD per share	0.96	1.67	1.13	1.51	0.80	1.32
Earnings per share, diluted‡ USD per share	0.95	1.66	1.09	1.48	0.79	1.32
Weighted average shares, basic‡ thousands of shares	14,243	14,413	15,448	15,963	16,529	16,669
Weighted average shares, diluted‡ thousands of shares	14,333	14,517	15,951	16,272	16,603	16,732

‡ Per-share figures and share counts are adjusted for the 1.5-for-1 stock split (March 2021); filings made before it reported them unadjusted.

Fiscal years (ALNT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	23,131	22,463	30,614	31,901	36,102	40,705
Accounts receivable	47,377	51,239	76,213	85,127	78,774	88,775
Inventory	62,978	89,733	117,108	117,686	111,517	109,198
Prepaid and other current assets	8,728	12,522	12,072	13,437	11,187	14,759
Total current assets	142,214	175,957	236,007	248,151	237,580	253,437
Property and equipment, net	55,428	56,983	68,640	67,463	65,685	61,771
Right-of-use asset	19,023	16,983	22,807	24,032	23,748	21,030
Goodwill	61,860	106,633	126,366	131,338	131,789	134,332
Total assets	349,197	470,785	588,347	597,542	575,781	577,595
Accounts payable	27,668	36,714	39,467	39,129	27,156	28,433
Accrued liabilities	24,862	41,656	48,121	56,488	30,221	40,890
Total current liabilities	52,530	78,370	87,588	95,617	57,377	69,323
Long-term debt	120,079	158,960	235,454	218,402	224,177	180,389
Lease liability, non-current	14,975	12,792	18,795	19,532	19,417	16,431
Total liabilities	206,141	283,023	372,882	345,967	310,927	276,140
Retained earnings	105,065	127,757	143,576	165,813	177,013	197,046
Total stockholders' equity	143,056	187,762	215,465	251,575	264,854	301,455
Total liabilities and equity	349,197	470,785	588,347	597,542	575,781	577,595
Common shares outstanding (cover page)‡ thousands of shares	14,659	15,462	16,067	16,593	16,845	16,940

‡ Per-share figures and share counts are adjusted for the 1.5-for-1 stock split (March 2021); filings made before it reported them unadjusted.

Fiscal years (ALNT's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Stock-based compensation	3,550	4,161	5,073	5,477	4,147	3,430
Depreciation and amortization	15,985	18,107	25,486	25,068	25,891	25,407
Net cash from operating activities	24,838	25,402	5,596	45,038	41,850	56,675
Purchases of property and equipment	9,371	13,716	15,910	11,603	9,683	6,989
Net cash from investing activities	(24,099)	(60,970)	(60,011)	(22,607)	(34,914)	(6,989)
Dividends paid	1,160	1,371	1,536	1,826	1,981	2,001
Proceeds from long-term debt	26,979	51,379	74,731	11,000	76,898	—
Repayments of long-term debt	16,897	12,248	—	—	—	—
Net cash from financing activities	7,489	35,832	63,605	(21,317)	(843)	(47,696)
Net change in cash	9,715	(668)	8,151	1,287	4,201	4,603

SIC 3825 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3825 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Allient	42,088	153,770	13,954*	17.0M	—	Q2 FY26 10-QJun 30, 2026
EyePoint	110,458	507	(62,348)*	86.2M	2.9 quarters	Q2 FY26 10-QJun 30, 2026
Transcat	5,758	97,090	10,148*	9.4M	—	Q2 FY27 10-QSep 26, 2026
Aehr Test Systems	116,358	18,835*	1,832*	32.6M	—	Q4 FY26 10-KMay 29, 2026
Cytek Biosciences	73,846	48,140	1,367*	130.0M	—	Q2 FY26 10-QJun 30, 2026
Senseonics Holdings	44,753	14,483	(30,138)*	52.9M	4.7 quarters	Q2 FY26 10-QJun 30, 2026
Pacific Biosciences of California	61,003	39,007	(35,583)*	310.8M	6.7 quarters	Q2 FY26 10-QJun 30, 2026
Mesa Laboratories	30,695	60,138	14,736	5.6M	—	Q1 FY27 10-QJun 30, 2026
Cohu	272,303	172,956	5,600*	47.3M	—	Q3 FY26 10-QSep 26, 2026

Not investment advice. Not affiliated with the U.S. SEC.